WallStreetZenWallStreetZen

NASDAQ: RYTM
Rhythm Pharmaceuticals Inc Stock Ownership - Who owns Rhythm Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Rhythm Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Hunter C. SmithChief Financial Officer2026-05-183,000$17.87
$53.61kBuy
Christopher Paul GermanCorporate Controller CAO2026-05-154,643$92.21
$428.13kSell
Christopher Paul GermanCorporate Controller CAO2026-05-151,687$56.69
$95.64kBuy
Christopher Paul GermanCorporate Controller CAO2026-05-151,349$49.23
$66.41kBuy
Christopher Paul GermanCorporate Controller CAO2026-05-151,406$17.97
$25.27kBuy
Christopher Paul GermanCorporate Controller CAO2026-03-041,500$17.97
$26.96kBuy
Christopher Paul GermanCorporate Controller CAO2026-03-045,614$89.56
$502.79kSell
Hunter C. SmithChief Financial Officer2026-03-026,099$6.80
$41.47kBuy
Christopher Paul GermanCorporate Controller CAO2026-03-01342$94.94
$32.47kSell
Hunter C. SmithChief Financial Officer2026-02-19800$102.10
$81.68kSell

1 of 10

RYTM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RYTM insiders and whales buy or sell their stock.

RYTM Shareholders

What type of owners hold Rhythm Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP9.73%6,666,837$584.41MInstitution
Blackrock Inc9.10%6,237,151$546.75MInstitution
Baker Bros Advisors LP8.18%5,604,483$491.29MInstitution
Ra Capital Management LP6.36%4,360,860$382.27MInsider
Primecap Management Co4.99%3,417,509$299.58MInstitution
Vanguard Portfolio Management LLC4.44%3,040,718$266.55MInstitution
Vanguard Capital Management LLC4.33%2,967,825$260.16MInstitution
Orbimed Advisors LLC4.01%2,750,079$241.07MInsider
Perceptive Advisors LLC3.46%2,373,795$208.09MInstitution
State Street Corp3.31%2,271,851$199.15MInstitution

1 of 3

RYTM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RYTM88.74%11.26%Net SellingNet Buying
MIRM56.48%43.52%Net BuyingNet Selling
CNTA91.39%8.61%Net SellingNet Selling
PTCT86.91%13.09%Net SellingNet Selling
LQDA50.69%49.31%Net SellingNet Selling
View Top Biotech Stocks

Rhythm Pharmaceuticals Stock Ownership FAQ

Who owns Rhythm Pharmaceuticals?

Rhythm Pharmaceuticals (NASDAQ: RYTM) is owned by 107.36% institutional shareholders, 13.63% Rhythm Pharmaceuticals insiders, and 0.00% retail investors. Ra Capital Management LP is the largest individual Rhythm Pharmaceuticals shareholder, owning 4.36M shares representing 6.36% of the company. Ra Capital Management LP's Rhythm Pharmaceuticals shares are currently valued at $385.41M.

If you're new to stock investing, here's how to buy Rhythm Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.